Cargando…
Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21
BACKGROUND: Non-invasive prenatal testing of trisomy 21 (T21) is being actively investigated using fetal-specific epigenetic markers (EPs) that are present in maternal plasma. Recently, 12 EPs on chromosome 21 were identified based on tissue-specific epigenetic characteristics between placenta and b...
Autores principales: | Lim, Ji Hyae, Lee, Da Eun, Park, So Yeon, Kim, Do Jin, Ahn, Hyun Kyong, Han, You Jung, Kim, Moon Young, Ryu, Hyun Mee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892082/ https://www.ncbi.nlm.nih.gov/pubmed/24397966 http://dx.doi.org/10.1186/1755-8794-7-1 |
Ejemplares similares
-
Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood
por: Lim, Ji Hyae, et al.
Publicado: (2013) -
Non-Invasive Prenatal Testing of Trisomy 18 by an Epigenetic Marker in First Trimester Maternal Plasma
por: Lee, Da Eun, et al.
Publicado: (2013) -
Non-Invasive Epigenetic Detection of Fetal Trisomy 21 in First Trimester Maternal Plasma
por: Lim, Ji Hyae, et al.
Publicado: (2011) -
Integrative analyses of genes and microRNA expressions in human trisomy 21 placentas
por: Lim, Ji Hyae, et al.
Publicado: (2018) -
Genome-wide gene expression analysis in the placenta from fetus with trisomy 21
por: Lim, Ji Hyae, et al.
Publicado: (2017)